CSIMarket
Company Name or its Symbol
Search for other Categories
 Search the Term
Health Care Terms
               
               
 Adenocarcinoma   LDL  
 Adenosine   Leucopenia  
 Adult Stem Cell   Lysate  
 Adverse Event   Lysates  
 Agonist   Mammography  
 AIDS   Marker  
 Alkylation Agent   Mast Cells  
 Allogeneic   Maximum Tolerated Dose  
 Amino Acid   Metastasis  
 Analgesic   Milestone  
 Analogues   Molecule  
 ANDA Abbreviated New Drug Application   Monoclonal Antibody  
 Angina   Mutation  
 Angiogenesis   NDA or New Drug Application  
 Angioplasty   Neuroscience   
 Antagonist   Neurotransmitter  
 Anti Hypertensive   Neutropenia  
 Antibody   Nucleic Acid  
 Antigen   Off-Label   
 API   Oncology  
 Arrhythmia   Open-label Clinical Trial  
 Arteriosclerosis   Orphan Drug   
 Atherosclerosis   Osteoarthritis  
 Autologous   Osteonecrosis  
 Balloon Angioplasty   Paediatric Exclusivity  
 Bioavailability   Partial Remission PR  
 Biologic Products   Passive Immunotherapy  
 Biomarker   Patent Term Extension  
 Bradycardia   Pathogen  
 Cancer   PBM  
 Cancer Stem Cell   Pharmacokinetics  
 Carcinomas   Pharmacology  
 Cardiovascular   Phase I Clinical Trial  
 Cardiovascular Disease CVD   Phase II Clinical Trial  
 Cell Growth   Phase IIb Clinical Trial  
 Cellular Differentiation   Phase III Clinical Trial  
 Chemotherapy    Phenotype  
 Cholesterol   Pivotal study or Pivotal trial   
 Clinical Data   Plasma  
 Clinical Development   PMA Pre-Marketing Approval   
 Colonoscopy   Pooled Analysis  
 Complete Response Letter   Pre-clinical  
 Compound   Preclinical Data  
 Computer Aided Drug Design   Preclinical Development  
 Confirmed Complete Remission CR   Product Candidate  
 Controlled Clinical Trial   Prognosis  
 Coronary Artery Disease CAD   Prospective Clinical Trial  
 Coronary Heart Disease CHD   Proteins  
 CRADA   Protocol  
 CTA   PS2 Patient  
 Cytokine   Qualified Person  
 Cytotoxicity   Radiolabeling  
 DEA Drug Enforcement Administration   Radiopharmaceutical  
 Diagnostic   Randomized Clinical Trial  
 Dialysis   Reagent  
 DNA Deoxyribonucleic Acid   Receptor  
 Dopamine   RECIST  
 Double-Blind Clinical Trial   Recombinant   
 Drug   Refractory  
 Drug Candidate   Regeneration  
 Endocrine   Regulatory Health Authorities  
 Endpoint   Renal Kidney  
 Enzymes   Resistance  
 Fast Track   Respiratory  
 FDA Food and Drug Administration   Retrovirus  
 Formulation   Second-line  
 Gene   Sensitivity  
 Gene Products   Side-Effect  
 Genomics    Small Molecule Drug  
 Genotype   Somatic Cell  
 Gland   Special Protocol Assessment or SPA  
 Glioblastoma Multiforme GBM   Spectrophotometer  
 Good Manufacturing Practice GMP   Standard of Care Treatment  
 Hazard Ratio HR   Stem Cell  
 HDL Cholesterol   Stenting  
 Hematopoietic Stem Cells   Sterol  
 Hemodialysis   Strain Bacterial  
 Hemofiltration Hemofiltrate   T cell  
 Hepatitis   Therapeutic  
 HIV   Therapeutic Products Directorate TPD  
 HMO Health maintenance organization   Toxicity  
 Homocysteine   Tuberculosis TB  
 Hypercholesterolemia   Unconfirmed complete remission CRu  
 Hyperlipoproteinemia   Urology  
 Immunocytochemistry   Vaccine  
 Immunogenic   Vascular  
 Immunoglobulin IgG   Vascular Access  
 In-vitro   Vasoactivity  
 In-vivo   WBC  
 Investigational Medicinal Product Dossier IMPD   Western Blot Analysis  
 Investigational New Drug IND   WHO  
 Isotoxic   Xenograft  
           
                 
Adenocarcinoma
LDL
Adenosine
Leucopenia
Adult Stem Cell
Lysate
Adverse Event
Lysates
Agonist
Mammography
AIDS
Marker
Alkylation Agent
Mast Cells
Allogeneic
Maximum Tolerated Dose
Amino Acid
Metastasis
Analgesic
Milestone
Analogues
Molecule
ANDA Abbreviated New Drug Application
Monoclonal Antibody
Angina
Mutation
Angiogenesis
NDA or New Drug Application
Angioplasty
Neuroscience 
Antagonist
Neurotransmitter
Anti Hypertensive
Neutropenia
Antibody
Nucleic Acid
Antigen
Off-Label
API
Oncology
Arrhythmia
Open-label Clinical Trial
Arteriosclerosis
Orphan Drug
Atherosclerosis
Osteoarthritis
Autologous
Osteonecrosis
Balloon Angioplasty
Paediatric Exclusivity
Bioavailability
Partial Remission PR
Biologic Products
Passive Immunotherapy
Biomarker
Patent Term Extension
Bradycardia
Pathogen
Cancer
PBM
Cancer Stem Cell
Pharmacokinetics
Carcinomas
Pharmacology
Cardiovascular
Phase I Clinical Trial
Cardiovascular Disease CVD
Phase II Clinical Trial
Cell Growth
Phase IIb Clinical Trial
Cellular Differentiation
Phase III Clinical Trial
Chemotherapy 
Phenotype
Cholesterol
Pivotal study or Pivotal trial
Clinical Data
Plasma
Clinical Development
PMA Pre-Marketing Approval
Colonoscopy
Pooled Analysis
Complete Response Letter
Pre-clinical
Compound
Preclinical Data
Computer Aided Drug Design
Preclinical Development
Confirmed Complete Remission CR
Product Candidate
Controlled Clinical Trial
Prognosis
Coronary Artery Disease CAD
Prospective Clinical Trial
Coronary Heart Disease CHD
Proteins
CRADA
Protocol
CTA
PS2 Patient
Cytokine
Qualified Person
Cytotoxicity
Radiolabeling
DEA Drug Enforcement Administration
Radiopharmaceutical
Diagnostic
Randomized Clinical Trial
Dialysis
Reagent
DNA Deoxyribonucleic Acid
Receptor
Dopamine
RECIST
Double-Blind Clinical Trial
Recombinant
Drug
Refractory
Drug Candidate
Regeneration
Endocrine
Regulatory Health Authorities
Endpoint
Renal Kidney
Enzymes
Resistance
Fast Track
Respiratory
FDA Food and Drug Administration
Retrovirus
Formulation
Second-line
Gene
Sensitivity
Gene Products
Side-Effect
Genomics
Small Molecule Drug
Genotype
Somatic Cell
Gland
Special Protocol Assessment or SPA
Glioblastoma Multiforme GBM
Spectrophotometer
Good Manufacturing Practice GMP
Standard of Care Treatment
Hazard Ratio HR
Stem Cell
HDL Cholesterol
Stenting
Hematopoietic Stem Cells
Sterol
Hemodialysis
Strain Bacterial
Hemofiltration Hemofiltrate
T cell
Hepatitis
Therapeutic
HIV
Therapeutic Products Directorate TPD
HMO Health maintenance organization
Toxicity
Homocysteine
Tuberculosis TB
Hypercholesterolemia
Unconfirmed complete remission CRu
Hyperlipoproteinemia
Urology
Immunocytochemistry
Vaccine
Immunogenic
Vascular
Immunoglobulin IgG
Vascular Access
In-vitro
Vasoactivity
In-vivo
WBC
Investigational Medicinal Product Dossier IMPD
Western Blot Analysis
Investigational New Drug IND
WHO
Isotoxic
Xenograft
             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

CREG's Profile

Stock Price

CREG's Financials

Business Description

Fundamentals

Charts & Quotes

CREG's News

Suppliers

CREG's Competitors

Customers & Markets

Economic Indicators

CREG's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms